Paul Tudor Jones Meridian Bioscience Inc Transaction History

Tudor Investment Corp Et Al

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$19.97 - $26.94 $803,552 - $1.08 Million	-40,238 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$17.46 - $21.61 $702,555 - $869,543	40,238 New	40,238 $821,000
Q2 2020 Aug 14, 2020	SELL	$7.84 - $23.29 $185,878 - $552,182	-23,709 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $30,896 - $63,790	5,547 Added 30.54%	23,709 $199,000
Q4 2019 Feb 14, 2020	SELL	$7.9 - $10.14 $594,064 - $762,507	-75,198 Reduced 80.55%	18,162 $177,000
Q3 2019 Nov 14, 2019	SELL	$9.17 - $12.01 $131,736 - $172,535	-14,366 Reduced 13.34%	93,360 $886,000
Q2 2019 Aug 14, 2019	BUY	$10.88 - $17.6 $490,905 - $794,112	45,120 Added 72.07%	107,726 $1.28 Million
Q1 2019 May 15, 2019	BUY	$15.51 - $17.61 $259,218 - $294,315	16,713 Added 36.42%	62,606 $1.1 Million
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $142,963 - $194,163	-9,846 Reduced 17.66%	45,893 $797,000
Q3 2018 Nov 14, 2018	BUY	$14.85 - $16.35 $112,414 - $123,769	7,570 Added 15.72%	55,739 $831,000
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $122,337 - $148,932	8,865 Added 22.55%	48,169 $766,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.2 $92,984 - $109,155	-6,738 Reduced 14.63%	39,304 $558,000
Q4 2017 Feb 14, 2018	SELL	$13.55 - $15.8 $47,994 - $55,963	-3,542 Reduced 7.14%	46,042 $645,000
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $666,904 - $711,530	49,584	49,584 $709,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.